The estimated Net Worth of Timothy J.R. Harris is at least 101 千$ dollars as of 19 May 2016. Timothy Harris owns over 43,716 units of Opgen Inc stock worth over 101,234$ and over the last 9 years Timothy sold OPGN stock worth over 0$.
Sign up
Timothy Harris OPGN stock SEC Form 4 insiders trading
Timothy has made over 1 trades of the Opgen Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Timothy bought 43,716 units of OPGN stock worth 88,306$ on 19 May 2016.
The largest trade Timothy's ever made was buying 43,716 units of Opgen Inc stock on 19 May 2016 worth over 88,306$. On average, Timothy trades about 4,857 units every 0 days since 2016. As of 19 May 2016 Timothy still owns at least 50,116 units of Opgen Inc stock.
You can see the complete history of Timothy Harris stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Timothy Harris's mailing address?
Timothy's mailing address filed with the SEC is 708 Quince Orchard Rd, Gaithersburg, MD 20878, USA.
Insiders trading at Opgen Inc
Over the last 9 years, insiders at Opgen Inc have traded over 12,018$ worth of Opgen Inc stock and bought 4,331,782 units worth 1,198,700$ . The most active insiders traders include Evan/ Fa Jones、Capital, Llcjones Evan/ Fa ...、Capital, Llc J Ven. On average, Opgen Inc executives and independent directors trade stock every 78 days with the average trade being worth of 280,277$. The most recent stock trade was executed by Johannes Bacher on 31 March 2023, trading 6,434 units of OPGN stock currently worth 12,997$.
What does Opgen Inc do?
opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.
What does Opgen Inc's logo look like?
Complete history of Timothy Harris stock trades at Opgen Inc
Opgen Inc executives and stock owners
Opgen Inc executives and other stock owners filed with the SEC include:
-
Dr. Oliver Schacht Ph.D.,
CEO, Pres & Director -
Dr. Oliver Schacht,
CEO, Pres & Director -
Timothy C. Dec,
CFO & Corp. Sec. -
Johannes Bacher,
Chief Operating Officer -
Dr. Arne Materna,
MD & CEO of Ares Genetics GmbH -
Derek Joesting,
Sr. VP of US Sales -
Albert Weber,
Chief Financial Officer -
Dr. Achim Plum,
Special Advisor of Ares Genetics GmbH -
Dr. Andreas Posch,
Special Advisor of Ares Genetics GmbH -
Christopher D. Emery,
Chief Commercial Officer for the Americas -
Dr. G. Terrance Walker Ph.D.,
Sr. VP of R&D -
Faranak Atrzadeh,
Chief Marketing & Scientific Affairs Officer -
Michael Farmer,
VP of Marketing -
Vadim Sapiro,
Chief Information Officer -
& Co., Inc.Merck Sharp & Do...,
-
Laurence Mc Carthy,
Director -
Capital, Llc J Ven,
10% owner -
Misti Ushio,
Director -
Timothy J.R. Harris,
Director -
Kevin Krenitsky,
President -
Brian G Atwood,
Director -
Timothy C Dec,
Chief Financial Officer -
Tina Susan Nova,
Director -
Evan/ Fa Jones,
Director -
Capital, Llcjones Evan/ Fa ...,
Chairman and CEOChief Executive Officer -
Vadim M. Sapiro,
Chief Information Officer -
R Don Elsey,
Director -
Matthew Charles Mc Murdo,
Director -
David Natan,
Director -
Avraham Ben Tzvi,
Director -
Mario Crovetto,
Director -
Johannes Bacher,
Chief Operating Officer -
Prabhavathi Fernandes,
Director -
William E. Rhodes,
Director -
Oliver Schacht,
Chief Executive Officer -
Albert Weber,
Chief Finanical Officer -
Yvonne Schlaeppi,
Director -
David E. Lazar,
Chief Executive Officer